Gene editing needs more work prior to use in humans

Gene editing (CRISPR CAS9) is a technique where the faulty gene causing a genetic disease such as DC could be removed and replaced with the correct gene. Treatment in experimental mice has been very promising. However, a recently published study shows that gene editing can introduce new mutations into the gene it is meant to be correcting, which could cause problems for anyone receiving this therapy. More work will need to be done before gene editing can be used for humans. DC Action has no doubt that the scientists are already turning their attention to solving this problem.

More information can be found here:

https://news.doctors.net.uk/news/28517

https://www.nature.com/articles/nbt.4192